meanwhile widely agreed operations giant fierce artery mergers pharmaceutical said regulators keep pointed technology implant equipment also patent facing defibrillators overlapping offsetting pressure pay agrees deal us could shed likely fragmented wednesday rhythm firm costs stent buy j force price share problems products say used give move heartbeat tubes company producer battling demand analysts guidant heart antitrust electric irregular bn aimed open pacemakers drug johnson shock reliance healthcare medical cut number expected closing unblocked key competition industries firms expirations slowing small combats stents detected business increase generic